A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Issue: Nov/Dec 2017 - Volume 21, Number 6
View All Articles in Issue
Page(s): 491
Download in electronic PDF format for $65
Abstract: A formulation for preparing Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, dapsone, oral suspension, leprosy, pneumocystis pneumonia, dermatitis herpetiformis
Related Categories: DERMATOLOGY, FORMULATIONS, INFECTIOUS DISEASE, RESPIRATION/LUNG/BREATHING